Highlights
A collection of news and information related to AstraZeneca Plc published by this site and its partners.
Displaying items 1-12 of 82
» View wsbt.com items only
1
2
3
4
5
6
7
•
Next >
-
End to Fed stimulus, China slowdown rattles swathe of world investments
ReutersLONDON (Reuters) - The U.S. Federal Reserve's explicit signal it will stop pumping money into the world economy and data showing China's economy slowing down swept across financial markets on Thursday, sinking bonds, shares and commodities alike....Tags: Travel, Herman Van Rompuy, Kendo, Thailand, Wars and Interventions
-
Reuters Science News Summary
ReutersFollowing is a summary of current science news briefs. With Russian help, Europe prepares to search for life on Mars PARIS (Reuters) - The European Space Agency signed final contracts with Thales Alenia Space Italy for work on a pair of missions to...Tags: Science, Space Programs, Cambridge (England), NASA, Science and Technology
-
Reuters Health News Summary
ReutersFollowing is a summary of current health news briefs. Analysis: Hospital investors sold on U.S. health reform despite bumps CHICAGO (Reuters) - Shares of U.S. hospital operators have been on a tear this year, on average posting triple the gains of the...Tags: Preventative Medicine, Glaucoma, Hospitals and Clinics, Obesity, Medical Research
-
Medicamento para diabetes de AstraZeneca y Bristol decepciona en ensayo clave
ReutersLONDRES, 19 jun (Reuters) - El medicamento de AstraZeneca y Bristol-Myers Squibb para la diabetes Onglyza no logró reducir los riesgos cardíacos en un importante estudio clínico, decepcionando a inversores que habían pensado que demostraría una...Tags: Lilly Eli & Co, Diabetes, Bristol Myers Squibb Company, Merck & Company Incorporated, Placebo
-
AstraZeneca picks its new home in Cambridge next to top hospital
ReutersLONDON, June 18 (Reuters) - AstraZeneca has chosen a science park in Cambridge, England, next to the world-renowned Addenbrooke's Hospital, as its new $500 million global headquarters and centre of drug research. Property industry sources told Reuters...Tags: Cambridge (England)
-
AstraZeneca picks site for new global home in Cambridge
ReutersLONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to the world-renowned Addenbrooke's Hospital, for its new $500 million global headquarters and research center. Property industry sources...Tags: Science, Medical Procedures and Tests, Research, Biology, MedImmune Inc.
-
AstraZeneca turnaround is 3-4 year journey, says CEO
ReutersLONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday. Speaking as the group unveiled...Tags: Diabetes, Bristol Myers Squibb Company, Cambridge (England), England, Drugs and Medicines
-
AstraZeneca, Bristol diabetes drug fails to show heart benefit
ReutersLONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study. The companies, which jointly sell several diabetes drugs, said on Wednesday the so-called SAVOR trial...Tags: Chemical Industry, Diabetes, Pharmaceuticals, Bristol Myers Squibb Company, Placebo
-
AstraZeneca, Bristol diabetes drug disappoints in key test
ReutersLONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals. The companies, which jointly sell...Tags: Bristol Myers Squibb Company, Merck & Company Incorporated, Placebo, Januvia (drug), Trials
-
BRIEF-AstraZeneca's MedImmune, NGM Biopharmaceuticals in deal to develop therapies for diabetes and obesity
ReutersLONDON, June 17 (Reuters) - AstraZeneca PLC : * Medimmune,NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity * MedImmune,NGM will jointly advance peptide and antibody drug candidates based on...Tags: Diabetes, Weight, MedImmune Inc., Obesity
-
AstraZeneca taps outside experts to screen cancer compounds
ReutersLONDON (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs. Scientists at the Cancer Research UK Paterson Institute for Cancer Research at the...Tags: Science, Research, United Kingdom, Science and Technology
-
PRINCIPALES NOTICIAS DEL MUNDO
ReutersLas siguientes son las principales noticias internacionales publicadas por Reuters el lunes 10 de junio. ...............................................................> NOTICIAS DESTACADAS S&P revisa panorama de EEUU a "estable" desde "negativo" Apple...Tags: G8, Google Inc.
Jun 20, 2013
|Story| Reuters
Jun 19, 2013
|Story| Reuters
Jun 19, 2013
|Story| Reuters
Jun 19, 2013
|Story| Reuters
Jun 18, 2013
|Story| Reuters
Jun 18, 2013
|Story| Reuters
Jun 18, 2013
|Story| Reuters
Jun 18, 2013
|Story| Reuters
Jun 19, 2013
|Story| Reuters
Jun 17, 2013
|Story| Reuters
Jun 13, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Original site for AstraZeneca Plc topic gallery.
